These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 24050409)

  • 1. Heart failure is associated with impaired anti-inflammatory and antioxidant properties of high-density lipoproteins.
    Kim JB; Hama S; Hough G; Navab M; Fogelman AM; Maclellan WR; Horwich TB; Fonarow GC
    Am J Cardiol; 2013 Dec; 112(11):1770-7. PubMed ID: 24050409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The functional and compositional properties of lipoproteins are altered in patients with metabolic syndrome with increased cholesteryl ester transfer protein activity.
    Park KH; Shin DG; Kim JR; Hong JH; Cho KH
    Int J Mol Med; 2010 Jan; 25(1):129-36. PubMed ID: 19956911
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The anti-oxidative capacity of high-density lipoprotein is reduced in acute coronary syndrome but not in stable coronary artery disease.
    Patel PJ; Khera AV; Jafri K; Wilensky RL; Rader DJ
    J Am Coll Cardiol; 2011 Nov; 58(20):2068-75. PubMed ID: 22051328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxidative stress and high-density lipoprotein function in Type I diabetes and end-stage renal disease.
    Kalogerakis G; Baker AM; Christov S; Rowley KG; Dwyer K; Winterbourn C; Best JD; Jenkins AJ
    Clin Sci (Lond); 2005 Jun; 108(6):497-506. PubMed ID: 15634192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating levels of linoleic acid and HDL-cholesterol are major determinants of 4-hydroxynonenal protein adducts in patients with heart failure.
    Asselin C; Ducharme A; Ntimbane T; Ruiz M; Fortier A; Guertin MC; Lavoie J; Diaz A; Levy E; Tardif JC; Des Rosiers C
    Redox Biol; 2014; 2():148-55. PubMed ID: 24494189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxidative stress and psoriasis: the effect of antitumour necrosis factor-α inhibitor treatment.
    Bacchetti T; Campanati A; Ferretti G; Simonetti O; Liberati G; Offidani AM
    Br J Dermatol; 2013 May; 168(5):984-9. PubMed ID: 23614561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extra-virgin olive oil consumption reduces the age-related decrease in HDL and paraoxonase 1 anti-inflammatory activities.
    Loued S; Berrougui H; Componova P; Ikhlef S; Helal O; Khalil A
    Br J Nutr; 2013 Oct; 110(7):1272-84. PubMed ID: 23510814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High levels of oxidized fatty acids in HDL are associated with impaired HDL function in patients with active rheumatoid arthritis.
    Charles-Schoeman C; Meriwether D; Lee YY; Shahbazian A; Reddy ST
    Clin Rheumatol; 2018 Mar; 37(3):615-622. PubMed ID: 29129008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human apolipoprotein A-II enrichment displaces paraoxonase from HDL and impairs its antioxidant properties: a new mechanism linking HDL protein composition and antiatherogenic potential.
    Ribas V; Sánchez-Quesada JL; Antón R; Camacho M; Julve J; Escolà-Gil JC; Vila L; Ordóñez-Llanos J; Blanco-Vaca F
    Circ Res; 2004 Oct; 95(8):789-97. PubMed ID: 15388641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lower serum paraoxonase-1 activity is related to higher serum amyloid a levels in metabolic syndrome.
    Kappelle PJ; Bijzet J; Hazenberg BP; Dullaart RP
    Arch Med Res; 2011 Apr; 42(3):219-25. PubMed ID: 21722818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HDL-paraoxonase and membrane lipid peroxidation: a comparison between healthy and obese subjects.
    Ferretti G; Bacchetti T; Masciangelo S; Bicchiega V
    Obesity (Silver Spring); 2010 Jun; 18(6):1079-84. PubMed ID: 19834469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of a short-term diet and exercise intervention on inflammatory/anti-inflammatory properties of HDL in overweight/obese men with cardiovascular risk factors.
    Roberts CK; Ng C; Hama S; Eliseo AJ; Barnard RJ
    J Appl Physiol (1985); 2006 Dec; 101(6):1727-32. PubMed ID: 16902063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Administration of high dose eicosapentaenoic acid enhances anti-inflammatory properties of high-density lipoprotein in Japanese patients with dyslipidemia.
    Tanaka N; Ishida T; Nagao M; Mori T; Monguchi T; Sasaki M; Mori K; Kondo K; Nakajima H; Honjo T; Irino Y; Toh R; Shinohara M; Hirata K
    Atherosclerosis; 2014 Dec; 237(2):577-83. PubMed ID: 25463091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-oxidative and cholesterol efflux capacities of high-density lipoprotein are reduced in ischaemic cardiomyopathy.
    Patel PJ; Khera AV; Wilensky RL; Rader DJ
    Eur J Heart Fail; 2013 Nov; 15(11):1215-9. PubMed ID: 23709232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-inflammatory and antioxidant properties of HDLs are impaired in type 2 diabetes.
    Morgantini C; Natali A; Boldrini B; Imaizumi S; Navab M; Fogelman AM; Ferrannini E; Reddy ST
    Diabetes; 2011 Oct; 60(10):2617-23. PubMed ID: 21852676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-density lipoprotein loses its anti-inflammatory capacity by accumulation of pro-inflammatory-serum amyloid A.
    Tölle M; Huang T; Schuchardt M; Jankowski V; Prüfer N; Jankowski J; Tietge UJ; Zidek W; van der Giet M
    Cardiovasc Res; 2012 Apr; 94(1):154-62. PubMed ID: 22328092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased low-density lipoprotein oxidation and impaired high-density lipoprotein antioxidant defense are associated with increased macrophage homing and atherosclerosis in dyslipidemic obese mice: LCAT gene transfer decreases atherosclerosis.
    Mertens A; Verhamme P; Bielicki JK; Phillips MC; Quarck R; Verreth W; Stengel D; Ninio E; Navab M; Mackness B; Mackness M; Holvoet P
    Circulation; 2003 Apr; 107(12):1640-6. PubMed ID: 12668499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibodies to high-density lipoprotein and beta2-glycoprotein I are inversely correlated with paraoxonase activity in systemic lupus erythematosus and primary antiphospholipid syndrome.
    Delgado Alves J; Ames PR; Donohue S; Stanyer L; Nourooz-Zadeh J; Ravirajan C; Isenberg DA
    Arthritis Rheum; 2002 Oct; 46(10):2686-94. PubMed ID: 12384928
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myeloperoxidase and paraoxonase-1 in type 2 diabetic patients.
    Jornayvaz FR; Brulhart-Meynet MC; James RW
    Nutr Metab Cardiovasc Dis; 2009 Nov; 19(9):613-9. PubMed ID: 19201174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impaired antioxidant activity of high-density lipoprotein in chronic kidney disease.
    Moradi H; Pahl MV; Elahimehr R; Vaziri ND
    Transl Res; 2009 Feb; 153(2):77-85. PubMed ID: 19138652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.